<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Studies with circulating <z:chebi fb="3" ids="33697">ribonucleic acid</z:chebi> (<z:chebi fb="40" ids="33697">RNA</z:chebi>) not only provide new targets for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> detection, but also open up the possibility of noninvasive gene expression profiling for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this paper, we developed a surface-enhanced Raman scattering (SERS), platform for detection and differentiation of serum <z:chebi fb="40" ids="33697">RNAs</z:chebi> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A novel three-dimensional (3-D), Ag nanofilm formed by dry MgSO(4) aggregated <z:chebi fb="0" ids="50826">silver nanoparticles</z:chebi>, Ag NP, as the SERS-active substrate was presented to effectively enhance the <z:chebi fb="40" ids="33697">RNA</z:chebi> Raman signals </plain></SENT>
<SENT sid="3" pm="."><plain>SERS measurements were performed on two groups of serum <z:chebi fb="40" ids="33697">RNA</z:chebi> samples </plain></SENT>
<SENT sid="4" pm="."><plain>One group from patients, n=55 with pathologically diagnosed <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and the other group from healthy controls, n=45 </plain></SENT>
<SENT sid="5" pm="."><plain>Tentative assignments of the Raman bands in the normalized SERS spectra demonstrated that there are differential expressions of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:chebi fb="40" ids="33697">RNAs</z:chebi> between the two groups </plain></SENT>
<SENT sid="6" pm="."><plain>Linear discriminate analysis, based on principal component analysis, generated features can differentiate the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> SERS spectra from <z:mpath ids='MPATH_458'>normal</z:mpath> SERS spectra with sensitivity of 89.1 percent and specificity of 95.6 percent </plain></SENT>
<SENT sid="7" pm="."><plain>This exploratory study demonstrated great potential for developing serum <z:chebi fb="40" ids="33697">RNA</z:chebi> SERS analysis into a useful clinical tool for label-free, noninvasive screening and detection of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
</text></document>